Trials / Unknown
UnknownNCT06271928
A Multicenter Clinical Study of Yijing Keli in the Treatment of Ovarian Aging
The Efficacy and Safety of Chinese Herbal Compound Yijing Keli in the Treatment of Ovarian Aging: A Multicenter and Prospective Study.
- Status
- Unknown
- Phase
- EARLY_Phase 1
- Study type
- Interventional
- Enrollment
- 100 (estimated)
- Sponsor
- Tongji Hospital · Academic / Other
- Sex
- Female
- Age
- 18 Years – 55 Years
- Healthy volunteers
- Not accepted
Summary
Ovarian aging (OA) seriously affects the physical and mental health of women. Nowadays, Chinese herbs have huge appeal and potential in treating OA. We have created a new Chinese herbal combination Yijing Keli, whereas its safety and efficacy still need to be validated. Hence, we will perform a population-based, multicenter study to confirm the safety and efficacy of Yijing Keli in therapy of OA. We aim to provide a solid evidence for TCM in therapy of OA.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Yijing Keli | Once enrolled, participants will be administrated Yijing Keli |
Timeline
- Start date
- 2021-10-01
- Primary completion
- 2024-01-01
- Completion
- 2025-01-01
- First posted
- 2024-02-22
- Last updated
- 2024-02-22
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT06271928. Inclusion in this directory is not an endorsement.